Heart Attack Therapy
New heart attack therapy research from Chinese Academy of Medical Sciences discussed
Published in Blood Weekly, February 22nd, 2007
New investigation results, "Carvedilol preserves endothelial junctions and reduces myocardial no-reflow after acute myocardial infarction and reperfusion," are detailed in a study published in International Journal of Cardiology. According to a study from Beijing, People's Republic of China, "Myocardial no-reflow, has been associated with alterations in endothelial junctions, which is regulated in part by endothelial dysfunction. Carvedilol is an alpha1 and nonselective beta-adrenergic receptor antagonist with antioxidative properties known to protect endothelial function."
"Therefore, we hypothesized that carvedilol might also have protective effects on myocardial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-02-22)
More Articles from Blood Weekly
- Blood Substitutes
New blood substitutes research has been reported by scientists at University of Massachusetts, Department of Chemical Engineering - Blood Substitutes
Reports summarize blood substitutes study results from Osaka University, Department of Ophthalmology - Blood Substitutes
Researchers from East China University of Science and Technology, Research Center provide details of new studies and findings in the area of blood substitutes - Hypotension Prevention
Studies from University of Texas, College of Pharmacy reveal new findings on hypotension prevention - Pneumonia Therapy
Research conducted at St. Louis College of Pharmacy, Department of Pharmacy Practice has updated our knowledge about pneumonia therapy - Sepsis
Investigators at University of Virginia, Cardiovascular Research Center release new data on sepsis - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
